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Abstract
Salmonella is an intracellular pathogenic, gram-negative, facultative anaerobe 
and non-spore-forming and usually a motile bacillus that leads to salmonellosis in 
the host. It is a common food-borne disease that ranges from local gastrointestinal 
inflammation and diarrhoea to life-threatening typhoid fever and presents usually 
a serious threat to public health due to its socio-economic value. Inadequate sanita-
tion and impure water help in the propagation of this disease. Despite advance-
ment in the sanitation standards, Salmonella enters the food chain and affects 
communities globally. There is an immediate need to develop improved vaccines 
to minimise Salmonella-related illnesses. Some Salmonella serovars infect a wide 
range of hosts, while others are known to be host restricted. Many different factors 
determine the adaptability and host specificity of Salmonella. The host-pathogen 
interactions play a unique role in Salmonella invasion and progression which needs 
to be studied in detail. This chapter shall focus on our current understanding of 
Salmonella invasion, pathogenesis and interactions with the host, host specificity 
and adaptability.
Keywords: Salmonella, serovars, adaptability, specificity, invasion,  
non-typhoidal Salmonella, typhoidal Salmonella, immune response
1. Introduction
Salmonellae are facultative anaerobes and gram-negative, non-spore-forming 
and usually motile bacilli. Two species, namely, Salmonella enterica and Salmonella 
bongori, belong to genus Salmonella. Salmonella enterica is further subdivided into 
six subspecies that are distinguished by variations in O (somatic) and H (flagellar) 
antigens with at least 2500 serotypes. S. enterica subsp. enterica comprises of more 
than half of the known serotypes [1]. New serotypes are being discovered increas-
ing the serotype complexity. Approximately 99% of the Salmonella serotypes that 
infect humans and other mammals belong to S. enterica subspecies. These serovars 
are mostly the inhabitants of intestinal tract of humans and other organisms that 
include reptiles, birds and insects. At farm level, sources of bacterial contamination 
are faecal matter, litter, feed and soil [2]. Salmonella most commonly causes food-
borne illnesses worldwide; the two commonly associated foods are eggs and poultry 
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meat [3]. Serovars S. Enteritidis, S. Typhimurium, S. Heidelberg and S. Newport 
are linked to such food-borne diseases, with farm animals being reservoirs for these 
serotypes [4, 5]. Salmonellosis is a big socio-economic threat worldwide that causes 
considerable mortality and morbidity in both humans and animals [6]. Most of the 
human-related diseases are food-borne, and exposure to these bacteria at different 
places has also been linked to human salmonellosis. The most orthodox mode of 
bacterial transmission is the faecal-oral route. Once the bacteria are transmitted, 
the initial site for bacterial infection is the small intestine. Following infection, 
different manifestations that arise range from gastroenteritis to enteric fever [7].
2. Epidemiology
The extensive investigation of the associated epidemiological risk factors that 
make an organism a persistent Salmonella carrier needs to be carried out. Non-
typhoidal Salmonella (NTS) infections that cause self-limiting manifestations are 
the most common to occur globally. In comparison, typhoidal Salmonella (TS) 
causing enteric fever leads to a high rate of mortality and morbidity that predomi-
nantly affects the underdeveloped countries [8]. Recent studies conclude that 
Salmonella Paratyphi A incidences have risen especially in South East Asia where 
approximately half of the TS-infected enteric fever patients are reported to be 
infected with S. Paratyphi A [9]. The food chain can get contaminated at any stage, 
and most of the transmission can occur by contaminated foods like poultry and 
dairy-related products. Apart from contaminated food products, NTS transmission 
can also result from person-to-person contact or from contact with other bacterial 
reservoirs. After gaining entry into the host, both TS and NTS serovars initially 
invade the intestinal epithelium of the small intestine.
3. Diseases caused by Salmonella infection
Salmonella species cause a varying number of clinical manifestations in the host 
that can range from self-limiting gastroenteritis typically associated with non-
typhoidal Salmonella (NTS) to typhoidal or paratyphoidal fevers, which can be 
life-threatening [6].
3.1 Typhoidal Salmonella (TS)
Humans are exclusive hosts for serovars such as S. Typhi, S. Sendai and  
S. Paratyphi A, B and C. These serovars are known as typhoidal serovars (TS) that 
can cause enteric fever/typhoidal/paratyphoidal fevers. Enteric fever is a systemic 
disease that is highly invasive and life threatening and is endemic in the developing 
world. Within an incubation period of around 2 weeks, bacteraemia occurs, which 
is marked by fever and malaise. The symptoms that start to appear after a week 
include fever, malaise, nausea, dry cough and abdominal discomfort. Common 
symptoms include tender abdomen, coated tongue, splenomegaly and hepato-
megaly [10]. As the lack of adequate water and sanitation facilities in the developing 
countries help in the spread of Salmonella through faecal-oral route [11], so to 
prevent typhoidal Salmonella transmission, societal standards need to be improved. 
The development of improved societal infrastructures is generally cost prohibitive 
in developing countries, hence, having little significance in reducing the disease 
frequency. In comparison, the development of effective and safe typhoidal vaccines 
can have a significant effect on reducing typhoidal cases.
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3.2 Non-typhoidal Salmonella (NTS)
Many industrialised and underdeveloped countries across the globe face a 
significant threat of non-typhoidal Salmonella (NTS). Worldwide, about 93.8 
million gastroenteritis cases arise from Salmonella infections leading to 1.5 million 
deaths annually [7]. In infants, young, aged and immunologically compromised 
subjects NTS cause invasive bacterial infection [12, 13]. After post infection with 
NTS, symptoms that arise last for about 10 days that triggers a massive inflamma-
tory response involving the release of pro-inflammatory cytokines and chemokines. 
The human NTS patients have higher serum levels of different interleukins and 
cytokines like IL-18, IL-12, IL-10, IL-15, TNF- α and IFN γ [14]. Non-typhoidal 
Salmonella serovars can cause severe extra-intestinal disease in patients with 
deficiencies in type 1 cytokine pathways such as IFN-γ/IL-12/IL-23 especially IL-12 
abnormalities. Effective vaccination against NTS is lacking as there is a greater 
variance among different serovars. So, for generating effective vaccines against 
NTS, knowledge regarding different target antigens needs to be studied in detail. To 
disrupt the bacterial transmission and the incidence, effective preventive measures 
such as improving sanitation, hygiene and drinking clean water must be taken into 
consideration. Different host specificities and adaptability are shown by different 
Salmonella serovars that shall be discussed in detail.
4. Host specificity and adaptation
Salmonellosis susceptibly ranges from organism to organism and can occur in 
almost all animal species, but the clinical severity of this disease varies among the 
hosts. There are only specific serovars that cause severe clinical manifestations in 
their specific hosts [15]. Although most of the serovars of S. enterica subspecies 
cause infections which give rise to gastroenteritis that lasts for short durations, 
some serovars lead to severe systemic illness in humans and animals accompanied 
by septicaemia, fever and in some cases abortion. Based on the host specific-
ity, these serovars can be grouped into two categories: the first category consists 
of serovars that are single-host restricted and the second category infecting a 
broad range of hosts. Different factors can be considered for grouping different 
serovars under the above-mentioned categories. Also, serovar pathogenicity and 
host epidemiology define host specificity. Keeping the above factors into account, 
different serovars have been grouped into three major groups. The first group 
comprises of serovars that mainly infect cattle and pigs but can also infect other 
animals including humans in some accidental cases. In this group, S. choleraesuis 
and dublin have been included that cause systemic diseases in the above-mentioned 
hosts. In humans and other animals, clinical symptoms may not be visible, thus 
making them asymptomatic. Salmonella carriers that can shed the bacteria in the 
surroundings thus leading to increased risk for susceptible hosts are also known as 
host-adapted serovars (HA) [16]. The second group infects specific hosts and is col-
lectively known as host-restricted (HR) serovars. The HR serovars cause systemic 
diseases and can sometimes prove lethal in their hosts that include poultry, humans, 
sheep, equine and pigs. This group includes S. gallinarum, S. typhi, S. abortus and 
S. abortusequi. They interfere with the environment of their hosts in a way that 
paves their way for invading the host. This ability to cause mammalian abortions 
and loss in poultry egg production is due to their remarkable ability to multiply in 
the foetal tissues [16–18]. The serovars of the third group are known as unrestricted 
serovars that are of zoonotic, epidemiological importance and impose a great threat 
to many animals and humans. The serovars of this group that are of much clinical 
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importance are S. typhimurium and S. enteritidis [18]. These cause mild symptoms in 
the adult host, and sometimes the host does not show any visible clinical symptoms 
despite infection. They severely invade young hosts as compared to adult hosts 
because the adult hosts have a well-built immune system that hinders the invasion 
by these serovars [16]. The host specificity and adaptability of different serovars are 
a complex process and involve many molecular mechanisms. The exact mechanisms 
are poorly studied, but certain factors have been found to be responsible for deter-
mining host specificity and adaptability.
4.1 Factors determining Salmonella host specificity and adaptation
Although the exact mechanisms to host specificity have not been fully deci-
phered, the existing evidence shows that serovars act independently of each other at 
the various phases of infection. The expression of serovar’s pathogenicity is affected 
by the environmental and genetic factors influencing each host during adaptation 
[19]. Each HA/HR serovar must overcome the encountered specific and non-
specific immune mechanisms. Thus, pathogenicity of HA serovars results from the 
development of ways helping their survival in a host. Examples of this are serovars 
of S. enterica subsp. enterica, which have developed the ability to evade the immune 
mechanisms of warm-blooded animals. They have, during their evolution, acquired 
the ability to modify to their favour the physiological functions of their host, such 
as intracellular engulfment, apoptosis, transfer of antigens by M (microfold) cells, 
migration of macrophages and lymphocytes in the reticuloendothelial system and 
others [20]. A well-known serovar S. typhi has evolved to survive in human macro-
phages making it pathogenic to man, but not to mice [21]. Serovars such as the HR 
S. typhi, S. gallinarum and S. abortusovis show high tropism for the lymphatic organs 
of their hosts, thereby regulating their natural host’s biological environment in their 
favour [19]. By anchoring to the cells of the bone marrow, PPs and bursa of 
Fabricius in the development of B cells, thus immune response is affected. The 
result of such interactions, particularly in adult animals, helps in the establishment 
of chronic or subclinical infection and thus prolonged subclinical excretion, but 
they do not help in the development of severe gastroenteritis [22]. Serovars not fully 
adapted to evade the mature immune system lack specificity, causing deadly 
systemic disease in adult animals by invading their defence mechanisms compared 
to HR serovars [20]. HR serovars are mildly enteropathogenic compared to the 
unrestricted serovars; thus, they do not cause intestinal inflammation [23]. It has 
also been shown that the ability of a serovar to metabolise a wide range of amino 
acids adds to its virulence and is thought to be closely related [24, 25]; however, HR 
or HA serovars have most likely evolved independently. On the other hand, the 
heterogenicity of serovars in relation to different metabolic profiles facilitates either 
the completion of the pathway to infection [26] or, when lacking specificity, it is 
favouring host adaptation [19]. The process of Salmonella host adaptation is 
believed to be involving either the loss of genes or the acquisition of novel genetic 
elements that encode specific virulence factors, and thus an inconvenience is 
observed frequently in the pathogenic strains. Best examples of host specificity 
dependent on gene deletions are, perhaps, of S. enteritidis, Typhimurium, 
Choleraesuis, Gallinarum, Abortusovis, Pullorum and Paratyphi C [27]. Genome 
sequencing of HA/HR serovars, such as Typhi, Gallinarum, Choleraesuis and the 
newly emerging in sub-Saharan Africa invasive strains of S. Typhi, has divulged 
that these have encountered extensive gene deletions and truncation [28, 29]. In 
systemically noninvasive Salmonella, the majority of lost genes have functional 
orthologues, which play a key role in intestinal colonisation, thus resulting in the 
loss of an intestinal multiplication cycle for narrowly host-adapted Salmonellae 
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followed by a concurrent acquisition of mechanisms helping the microorganism to 
survive in a systemic niche [30]. Point mutations, horizontal gene transfer, positive 
selection and genome degradation could be responsible for a differential pathoad-
aptive evolution of some Salmonella serovars [31]. It appears from the analysis of 
the mannose-sensitive fimbrial adhesin FimH that even single amino acid replace-
ment, resulting in specific structural mutations in FimH variants of HA serovars, 
plays an important role in the differential adaptive evolution of Salmonella spp. 
Thus, activation or inactivation of mannose-specific adhesive properties in differ-
ent systemically invasive serovars reflects the dynamic trajectories of adaptation to 
the biological environment of a specific host. Furthermore, phylogenetic analysis 
has indicated that these mutations are, most likely, of a convergent nature (common 
pathogenic traits incorporated into different genetic backgrounds) and occur under 
strong positive selection, illustrative of the role of point amino acid changes for HA 
Salmonella. Certainly, deep study for the molecular composition of flagella, chemo-
taxis genes [32], fimbriae and bacteriophages and the presence of virulence plas-
mids and subtypes of each specific serovar is needed, to understand mechanisms of 
pathogenicity and host specificity [19]. Correlation between some phage types of  
S. Typhi with their hosts has shown considerable host specificity [33]. However, the 
majority of phage types studied had a broad host range, perhaps, suggesting a phage 
transfer of virulent genes between hosts, leading eventually to host specificity. The 
unrestricted serovar Typhimurium may comprise a spectrum of variants differing 
in regard to virulence, reflecting a summation of the spatial and/or temporal 
selective pressures within a particular host [34]. Salmonella Typhimurium strains 
derived from animal cases were also virulent in mice, whereas many strains derived 
from a clinically ill man lacked this ability. Of interest was that many derived from 
human gastroenteritis lacked the Salmonella virulence plasmid, present in all 
animal strains and strains isolated from human bacteraemia. Furthermore, some 
strains harbouring the virulence plasmid isolated from the man were avirulent in 
mice, and the opposite was observed with those derived from animals. Altogether, 
isolates of a specific bacterial serovar obtained from human salmonellosis are 
different from those isolated from animals. This means that selective pressure 
within a specific host gives rise to bacterial strain variants that exhibit different 
pathogenicity determinants, thus varying degree of pathogenicity. Similarly, 
serovars of S. enterica subsp. enterica, associated with disease in mammals and 
birds, show different degrees of adaptability. Pathogenicity determinants, such as 
the FimH adhesins, play an important role. Type 1 FimH adhesins are expressed by 
serovars of S. enterica isolated from mammalian and avian hosts, while type 2 FimH 
is expressed exclusively by the avian-adapted serovar Gallinarum. Allelic variation 
of the S. enterica FimH adhesin directs host-cell-specific recognition, thus selec-
tively binding to mammalian or avian receptors [35]. The distribution of SPIs, 
fimbriae operons and virulence plasmids has shown that various combinations of 
virulent determinants formed during the evolution of the microorganism are 
needed for a variant to become pathogenic in a particular range of host species. 
Mutations horizontally transmitted could have helped the development of host 
specificity by helping Salmonella serovars to harbour unique virulence factors [36]. 
Molecular and phylogenetic analyses of the SPI genes showed that these encode for 
translocon proteins (SipD, SseC and SseD) present on both Salmonella pathogenic-
ity islands SPI-1 and SPI-2 and also encode an effector protein that inhibits the 
MAPK pathway of the host cells [37]. In addition, they encode effector proteins 
(SseF and SifA) important in placing the Salmonella-containing vacuole (SCV) in a 
juxtanuclear position. The products of SPI genes interact directly with the host and 
modulate its functions, thus favouring host specificity. Another study of the SPI 
genes has shown the close evolutionary relatedness between serovars Gallinarum 
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and Enteritidis [38], although the former is highly adapted (restricted) to poultry 
and is the only known non-motile serovar, while serovar Enteritidis is unrestricted. 
Analysis of the functions of genes associated to SPI-1 showed that virulence genes 
might have evolved under positive selection imposed by a serovar’s respective 
host(s) contributing to the different host specificity observed between different 
serovars. This has displayed that a close similarity of core regions exists within as 
well as among different serovar genomes [39]. In particular, genomic comparisons 
of HR and HA serovars show that genomic degradation is a common evolutionary 
mechanism for host adaptation and increased pathogenicity [39, 40]. Others have 
shown that host restriction and change of ecological niche are associated with the 
accumulation of pseudogenes and an overall reduction in genome size [28]. For 
example, S. Typhi and Paratyphi A are restricted to the man and cause a similar 
systemic disease. Genome sequence similarity between Typhi and Paratyphi A 
serovars and their different pathogenicity when compared to the unrestricted 
serovars of S. enterica have been attributed to a relatively recent recombination of a 
quarter of their genomes, making the aggregation of pseudogenes a key feature of 
convergent evolution for these and other HA pathogens [31]. Another example 
supporting the role of convergent evolution is serovar Paratyphi C, which has 
diverged from the same ancestor as serovar Choleraesuis, by accumulating genomic 
novelty during its adaptation process to man. The genomic analysis of these two 
Salmonella serovars has revealed a highly similar genomic construction between the 
two and their distinct pathogenic features, making them excellent models for 
studying Salmonella’s host adaptation and pathogenic divergence [39]. Hence, 
Salmonella adaptation to a particular host species is a complex phenomenon, which 
depends, apparently, on a large number of gene products. The prowess of under-
standing host-pathogen interactions requires analysis of the physiological associa-
tions between various animal species and genetic composition.
5. Salmonella invasion
After ingestion of Salmonella by the host organism, it travels from the stomach 
and invades intestinal epithelial cells. Bacterial recognition generates an inflam-
matory response following the recruitment of a variety of bone-marrow-derived 
phagocytes [41]. The ability of Salmonella to access intestinal epithelium (M cells) is 
due to the presence of virulence genes encoded by Salmonella pathogenicity island 
1 (SPI-1). Proteins that are encoded by SPI-1 form a needle-like Type III secretion 
system which allows the transport of several bacterial proteins into the host cell 
cytosol. These proteins induce changes in the host cells such as the rearrangement of 
the cytoskeleton and cell membrane and disconnection of epithelial cell junctions, 
facilitating bacterial invasion [42]. The primary site of Salmonella infection occurs 
at specialised microfold, or M cells, that are dispersed among the enterocytes, 
covering the follicle-associated epithelium (FAE) of the Peyer’s patch (PP) [43] 
(Figure 1). Salmonella is considered to preferentially invade PPs in the distal ileum, 
but in practice, all intestinal PPs will harbour bacteria after moderate-to-high-dose 
infection. Once Salmonella is penetrated, it initiates destruction of M cell which 
disrupts the mucosal barrier and allows additional entry of bacteria through neigh-
bouring enterocytes [43]. This process is extremely efficient, with M-cell penetra-
tion followed by M-cell destruction. Once access to PP via FAE is gained, invading 
bacteria enter the lymphatic system where they interact with professional killing 
cells (phagocytes) that ultimately determine the fate of the infection. Phagocytes 
are involved in both oxygen-dependent and oxygen-independent killing of the 
engulfed bacteria. During intestinal NTS infection, the release of reactive oxygen 
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and nitrogen species creates a highly oxidative environment which is not permissive 
for the growth of bacteria. The subepithelial dome also contains dendritic cell (DC) 
subsets apart from macrophage populations, each of which can phagocytise the 
bacteria and then undergo apoptosis through a caspase-1-dependent mechanism 
[44]. Consequently, during Salmonella infection, the number of obligate anaerobes 
decline in the gut. Also, host-signalling environment is highly crucial for the disease 
development initiated by contact between microbe and host cells in various tissues, 
largely mediated by cytokine signalling. These cytokines aid in initiating and regu-
lating the innate and adaptive branches of the immune response against Salmonella. 
In order to avoid damage to the host, the release of pro- and anti-inflammatory 
cytokines must be balanced [45]. M cells are not only abundant in PPs; they also 
predominate in other intestinal locations and so can, therefore, mediate infection of 
non-PP intestinal tissues (Figure 1). The most likely non-PP entry route is through 
the bacterial invasion of solitary intestinal lymphoid tissues (SILTs), which are het-
erogeneous intestinal lymphoid aggregates found in mice and humans that contain 
Figure 1. 
Salmonella entry in intestinal epithelial cells. SPI-1 facilitates uptake and destruction of M cells, SILTs. After 
invasion of under tissues, Salmonella is taken by phagocytes and transported to mesenteric lymph nodes.
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certain features of PPs, including the presence of FAE-containing M cells [46, 47]. 
These SILTs are invaded by bacteria in a much similar manner as described above 
for PPs [48]. SILTs can be important in humans since in a study of typhoid patients, 
both PPs and SILTs showed inflammation. It has also been reported that intravillous 
M cells, which are sparsely located along the intestinal tract, may serve as a portal 
of entry for invasive Salmonella bacteria [49, 50] (Figure 1).
5.1 Alternative route for invasion
The main entry route described above involve, bacterial interactions with M 
cells, the possibility is that it can invade the host by an alternative route that does not 
involve M cells. A population of phagocytes in the lamina propria capture bacteria 
directly from luminal contents which also allow bacterial entry [51, 52]. This is for 
those bacteria that lack SPI-1 genes as this route does not involve M cell-mediated 
uptake. These cells might have been referred to as DCs, but as this is not clear [53, 54], 
they will be referred to as lamina propria phagocytes in this chapter. Although this 
pathway has now become an alternative to our general understanding of bacterial 
entry through M cells, the physiological importance of this route to systemic salmo-
nellosis is poorly defined. The compelling evidence for a non-M-cell pathway is largely 
derived from microbiological and immunological investigations. Recent interest was 
stimulated by demonstrating that strains lacking SPI-1 and the fimbrial lpfC gene that 
did not normally infect mice retained the ability to infect mice in a CD18-dependent 
manner and were rapidly detected in the blood after oral inoculation [55, 56]. This 
extremely rapid dissemination to the blood and lack of serovar specificity might be 
due to bacterial entry in the bloodstream of the host through abrasions caused during 
gavage. Many cervical lymph node infection cases that attributed to the entry through 
mucosal abrasions during gavage were revealed through bacterial imaging system 
[57]. Expression of the SPI-2 type-III secretion system effector protein (SrfH) of 
bacteria was required for very early dissemination of bacteria to the blood and spleen 
[58]. This finding supports the idea that rapid entry through an alternative pathway 
involves active processes, so, therefore, it is important to examine this route from a 
microbiological perspective. In vitro studies demonstrated that DCs could capture 
bacteria by extending processes between the tight junctions of a monolayer and the 
apical surface of epithelial cells [59]. Subsequently, a similar process was directly visu-
alised in vivo when CX3CR1-expressing phagocytes were detected extending tran-
sepithelial dendrites in the lamina propria, and the number of dendrites increased 
in the terminal ileum after infection [60]. So, these studies suggested an alternative 
entry model, whereby Salmonella might commonly access the intestinal lamina pro-
pria by cell sampling, as large numbers of bacteria were detected within the lamina 
propria [60]. However, Salmonella is not normally recoverable in large numbers 
from the lamina propria unless the bacterial flora is first depleted before infection 
[48]. Also, the formation of transepithelial dendrites is dispensable for the uptake of 
other pathogenic microorganisms [61]. More importantly, it has been demonstrated 
that CX3CR1+ lamina propria cells are unlikely to migrate to the mesenteric lymph 
nodes (MLN) and have poor immunostimulatory capacity [53]. Thus, CX3CR1+ cells 
most likely represent a population of non-migrating phagocytes that provide innate 
immune defence against infection within the lamina propria. Surprisingly, the role 
of cell-mediated uptake has not been examined carefully in PPs or in SILTs, but still, 
phagocytic cells are often found in association with the epithelium of tissues [48, 62]. 
In summary, a prominent role for M cell-mediated intestinal entry by Salmonella is 
played both in the PPs and SILTs, whereas Salmonella entry of the lamina propria and 
the mechanisms like immune activation and bacterial dissemination associated with 
this pathway of entry remain largely speculative.
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6.  Salmonella infection of mesenteric lymph nodes (MLNs) and systemic 
tissues
After initial invasion through PPs, the ultimate fate of infection is decided in 
the lymphatic system. The indication for the bacterial migration is based on our 
understanding of the lymph and the conjectural finding that bacteria are detected 
initially in PPs, followed by the MLN and finally the liver and spleen [63, 64]. 
Salmonella after getting access to efferent lymphatics reaches the systemic tissues 
via the thoracic duct and blood after reaching the MLN [65, 66]. The immune cell 
population that aids in the transport of bacteria to the blood and other tissues is 
not well known; however, intestinal DCs are usually considered as a possibility. 
The majority of bacteria were found free in the lymph or were associated with 
non-DC phagocytes [67], but it is not clear whether this also occurs during exit 
from the MLN. Disseminated bacteria show a tropism of tissues that contain a high 
number of phagocytic cells, and in most circumstances, this involves the spleen, 
liver, and bone marrow [65, 68]. Disruption of erythropoiesis and splenomegaly by 
Salmonella can be explained majorly by the expansion of immature erythrocytes 
in the spleen in an erythropoietin-dependent manner. Cancer studies have demon-
strated that bacteria preferentially accumulate in primary and metastatic tumours 
[69, 70], suggesting that it does not have a precise organ tropism but finds tissues 
that contain a sufficient number of cells that support bacterial replication. The 
large size of the spleen, liver, and bone marrow means that these tissues gradually 
comprise the major sites of bacterial replication [71, 72]. Thus, Salmonella causes 
systemic infection that uses intestinal lymphoid tissues as a portal of entry. Also 
that bacteria clearance from the host and resistance to secondary infection requires 
the coordinated action of both systemic and mucosal immunity.
7. Host innate immune response to Salmonella
After phagocytosis by macrophages, Salmonella can survive and replicate within 
modified intracellular vesicles, termed as Salmonella-containing vacuoles (SCV) 
[73, 74]. The ability of Salmonella to survive within the phagosome is mediated by 
SPI-2, which prevents movement of RNS and ROS into the phagosome where the 
bacteria reside [75, 76]. In addition, Salmonella phoP/phoQ regulon inhibits fusion 
of the SCV with toxic lysosomes and endosomes [77]. The natural resistance-
associated macrophage protein encoding gene, which enables macrophages to 
transport ions into the SCV, provides resistance/susceptibility to infection [78]. 
Survival of bacteria intracellularly within tissue phagocytes is a prerequisite to 
the bacterial virulence, and bacterial mutants that cannot survive and replicate 
within macrophages are attenuated for virulence [79]. The initial invasion induces 
a massive inflammatory response, characterised by recruitment of neutrophils, 
DCs, inflammatory monocytes and macrophages [48, 80]. Neutrophils follow the 
chemokine gradient to the gut and extravagate into the mucosa. As they encounter 
and eliminate the bacteria by mechanisms that are not yet fully elucidated [81], 
neutrophils are believed to be important in preventing dissemination of the bacteria 
from the intestine to systemic tissues, so the patients with low neutrophil levels 
have a high risk of bacteraemia during infection with NTS strains [82]. Also, that 
depletion of neutrophils allows extracellular growth of bacteria, suggesting that 
neutrophils confine and reduce bacterial replication immediately after entry. 
Inflammatory monocytes are an important source of antimicrobial factors, such as 
TNFs and inducible NO synthase, during the initial stages of infection [80]. Myd88-
dependent chemokine production within the PPs drives the recruitment of these 
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inflammatory cells [81]. Indeed, Salmonella expresses several pathogen-associated 
molecular patterns (PAMPs), including lipopolysaccharide (LPS) and flagellin, 
which can be detected by Toll-like receptors (TLRs) expressed by enterocytes 
and phagocytes [83]. Also, macrophages after sensing cytosolic flagellin through 
NLRC4 (also known as Ipaf) activate caspase-1 and induce the production of IL-18 
(pro-inflammatory) [84, 85]. Dendritic cells are professional antigen-presenting 
cells and increase the expression of MHC class II and the co-stimulatory molecules 
CD86, CD80 and CD40 by responding to the recognition of Salmonella LPS or 
flagellin [86, 87]. DCs present antigen to naive CD4+ T cells, thus providing a vital 
link between innate immune responses and the induction of adaptive immunity. In 
the PPs, flagellin also induces the secretion of the inflammatory chemokine CCL20, 
which is an important ligand for CCR6 [88]. This response activates an early process 
whereby CCR6-expressing DCs are recruited to the FAE, for efficient activation of 
CD4+ T cells [89].
8. Host-adaptive immune response to Salmonella
Adaptive immune response to Salmonella can be mediated via early CD4+ T-cell 
activation. Due to the small size of intestinal lymphoid tissues and low frequency 
of naive CD4+ T cells specific for any given antigen [90], detecting initial bacte-
rial specific T-cell activation in these tissues is challenging. However, studies 
with T-cell receptor transgenic mice visualised the processes of bacterial specific 
CD4+ T cells responding to oral infection [64, 91]. An artificially elevated naive 
precursor frequency of CD4+ T cells at a high dose of infection provides the most 
accurate assessment of Salmonella-specific CD4+ T-cell activation [92]. The earliest 
Salmonella-specific CD4+ T-cell activation occurs within the MLN after oral infec-
tion but usually peaks few hours after that in the PPs [91]. At very early time points, 
CD4+ T cells were not found to be activated in any other secondary lymphoid tissues 
[89], suggesting that whatever the explanation for early bacterial dissemination to 
blood as discussed above, no early adaptive immune response is initiated outside 
the gut-associated lymphoid tissue. Interestingly, the T-cell receptor transgenic 
model used recognises a bacterial peptide from the carboxy-terminal region of 
flagellin [93] which is also a ligand for TLR5 [94]. Generally, the early activation 
of flagellin-specific CD4+ T cells in the PPs is representative of the naive CD4+ 
response to other bacterial antigens [95, 96]. However, this is difficult to demon-
strate conclusively as very few, naturally occurring bacterial specific MHC class-II 
peptides are known [97]. Interestingly, activation of CD4+ T cells in the MLN is also 
dependent on CD11c+ DCs and CCR6, indicating that T-cell activation in the MLN 
and PP has similar requirements. The evidence clearly suggests that the MLNs are 
an important site for immune protection during the course of Salmonella infection. 
Indeed, after MLNs were surgically removed, there was an elevated bacterial load 
and severe immunopathology in the liver [98]. The importance was also highlighted 
using a relapsing model of murine typhoid in which primary infection returns after 
apparent antibiotic clearance [57]. Although MLN is often considered a potential 
site of bacterial accumulation [99, 100], it acts as a protective firewall, preventing 
bacterial dissemination and relapsing Salmonella infection.
9. Host effector responses against Salmonella
The development of robust protective immunity against Salmonella infec-
tion requires the coordination of B and T cells. One hundred and sixteen CD4+ T 
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cells have a critical role in clearing the primary infection and are also required for 
acquired resistance to secondary infection [100]. In contrast, B cells are dispensable 
for resolving primary infection but are required for protection against secondary 
challenge [101]. There is a massive expansion of Salmonella-specific CD4+ T cells 
and rapid acquisition of Th1 effector functions, i.e. the enhanced ability to secrete 
INF-γ, TNF α and IL-2 upon restimulation [102] (Figure 2). These activated Th1 
cells can be clearly detected a week after infection, which is consistent with the rapid 
tempo of CD4+ T-cell activation. Optimal expansion of Th1 cells have been shown to 
require expression of both programmed death ligand-1 (PD-L1) and the TNF recep-
tor family members, OX40 and CD30. Appropriately, expansion of activated Th1 
cells eventually comprises ~50% of all CD4+ T cells few weeks after infection [103]. 
Furthermore, Th1 cells are capable of responding to innate signals such as Salmonella 
LPS by secreting cytokines [104]. This innate response is unexpected as effector Th1 
cells are normally stimulated only after recognition of cognate peptide and MHCs 
[105]. This innate immune responsiveness suggests a means by which the host can 
rapidly produce INF-γ to activate macrophages within an infected tissue, even if 
bacteria are capable of inhibiting antigen presentation by infected phagocytes [106]. 
Despite the rapid and efficient development of Th1 effector cells, there is actually 
little evidence that suggests their contribution to bacterial clearance during primary 
infection. Thus, it was found that when CD4+ or CD4+ Th1 cells were completely 
absent, bacterial growth enhanced a few weeks after infection which indicates that 
Th1 cells contribute little to regulate bacterial growth before this point [107]. Many 
in vitro studies point to an inhibitory effect of Salmonella on antigen presentation to 
naive T cells in vitro [108], but in vivo, there is no effect on Salmonella-specific CD4+ 
expansion [109]. In contrast, the gradual loss of effector CD4+ T cells detected in the 
process of Salmonella infection that required the presence of live bacteria and the 
expression of SPI-2 genes indicated that the effector function of cells is specifically 
Figure 2. 
Induction of IFN γ production by Salmonella-specific CD4+T cells. Expansion of activated CD4+T cells in 
secondary lymphoid tissues which in turn produces IFNγ at infection sites. Production of IFNγ finally activates 
macrophages.
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inhibited by actively replicating bacteria [110]. Effector Th1 cells are effective in 
providing immunity to salmonellosis [111]; however, effector CD4+ subsets includ-
ing regulatory T cells (Tregs) and Th17 cells are also known to contribute. Tregs arise 
from the thymus or develop after naive T-cell activation in the presence of TNF β 
which suppresses effector T-cell responses [112]. In contrast, Th17 cells arise from 
naive CD4+ T-cell stimulation in the presence of IL-6 and TNF-β and are important 
in mediating immunity against extracellular bacterial infections [113, 114]. During 
the development of Th1 cells and Tregs after infection, it was found that changes in 
the cogency of Tregs reduced the efficacy of Th1 responses and increased bacterial 
growth [102]. After oral infection with Salmonella, cytokines associated with Th17 
cells, IL-17 and IL-22 are rapidly produced within the intestinal mucosa [115], and 
the production is induced by innate responses to infection rather than Th17 cells, 
however, still indicating the potential for Th17 cytokines to participate in intestinal 
defence against bacteria. In vivo, production of IL-22 dependent on IL12B, rather 
than IL-17, contributed to bacterial clearance [116]. Taken together, it is suggested 
that Th17 cells contribute additionally to protection against Salmonella infection by 
not only initiating or enhancing neutrophil infiltration to intestinal tissues but by 
the production of antimicrobial peptides by the epithelium which is effective against 
luminal bacteria as well [117]. In summary, it has been suggested that Th17 cells have 
an additional role in defence against Salmonella in the intestine and a role for Tregs in 
modulating the potency of Salmonella-specific Th1 cells in vivo.
10. Host antibody (Ab) response against Salmonella
Salmonella-specific B-cell responses contribute to bacterial clearance in the hosts 
[39, 120, 121]. Although the bacteria are generally found within SCV in phagocytic 
cells, there is a short period during the infection cycle when bacteria are expected to 
be extracellular. Salmonella is not only tightly associated with mononuclear phago-
cytes in vivo [118] but also induces these infected cells to undergo apoptosis [44]. 
After cell death, bacteria are presumably found in the extracellular compartment 
before infecting a neighbouring phagocyte. Thus, antibody might have direct access to 
the bacteria during this short period of time and prevent cell-to-cell transmission [92]. 
Bacterial colonisation obstructs the bacterial opsonization with Salmonella-specific 
Ab [119]. The Ab also plays a role in amplifying the processing and presentation of 
antigens to CD4+ T cells, thus affecting the Th1 response [120]. B-cell innate immune 
response to TLR-specific ligands is necessary for the development of Th1 responses 
in vivo [121]. New findings also suggest the suppression of protective immunity 
through B-cell MyD88 pathway during infection [122]. Therefore, innate immune sig-
nalling in B cells contributes to an important regulatory function but requires further 
analysis. The presence of Salmonella-specific Ab IgA in the intestinal mucosa may also 
prevent or reduce bacterial penetration of the intestinal barrier [123]. However, which 
of these mechanisms makes the greatest contribution to protective immunity is yet 
to be deciphered, but an important role for Ab is also suggested from human studies 
[124]. Although the specificity of Ab responses is undefined, Abs specific for the LPS 
O-antigen, flagellin, Vi capsular polysaccharide (ViCPS) antigen and outer membrane 
porin protein (OmpD) are all believed to be protective [125].
11. Conclusion
Members belonging to genus Salmonella are the major intestinal pathogens of 
human beings and animals. The increased food production and growth in human 
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populations have led to the increase in dissemination potential of these ubiquitous 
microorganisms. Due to the systemic nature of some infections, where many tis-
sues get involved to display immunity to specific infection, salmonellosis and the 
immune response that results are pliable. Deciphering the pathogenesis of invasive 
salmonellosis may hopefully lead to potential therapeutic treatment strategies 
that are urgently required in light of propagating antimicrobial resistance. Future 
studies must focus on the identification of molecular targets of Salmonella virulence 
factors during intracellular life in immune cells and designate the molecular mecha-
nisms of interference. This would impart a novel perception into the cell biology 
of DCs and other immune cells. Furthermore, understanding the intracellular life 
of Salmonella may lead to new advancement in generating reliable vaccines against 
infections, to wield Salmonella strains as live carriers for recombinant vaccines and 
to evolve novel forms of treatment that target the function of specific virulence 
factors. Further explorations to clarify the contribution of genes differently repre-
sented/expressed in the genomes of various Salmonella serotypes during infection 
are required.
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